| 000 | 01721 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511195146.0 | ||
| 264 | 0 | _c19920901 | |
| 008 | 199209s 0 0 eng d | ||
| 022 | _a0148-396X | ||
| 024 | 7 |
_a10.1227/00006123-199207000-00013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatts, R G | |
| 245 | 0 | 0 |
_aCerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma. _h[electronic resource] |
| 260 |
_bNeurosurgery _cJul 1992 |
||
| 300 |
_a89-98; discussion 98-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xblood supply |
| 650 | 0 | 4 |
_aBrain Neoplasms _xpathology |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aGlioma _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intralesional |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aNecrosis |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aMerchant, R E | |
| 773 | 0 |
_tNeurosurgery _gvol. 31 _gno. 1 _gp. 89-98; discussion 98-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1227/00006123-199207000-00013 _zAvailable from publisher's website |
| 999 |
_c1647592 _d1647592 |
||